MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokinesHyun-Min Ryu(University of Ulsan), Ki Hyeong Lee(University of Ulsan)Cellular and Molecular Life SciencesAugust 20, 202510.1007/s00018-025-05791-wCited by 0SaveCiteExport RISWatch citationsRelated PapersMED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines|Research Square|2025|0